Anavex Life Sciences Corp

(NASDAQ:AVXL)

Latest On Anavex Life Sciences Corp (AVXL):

Date/Time Type Description Signal Details
2023-05-09 09:59 ESTNewsAnavex Life Sciences GAAP EPS of -$0.17 beats by $0.01N/A
2023-05-09 09:59 ESTNewsAnavex Life Sciences Corp. (AVXL) Q2 2023 Earnings Call TranscriptN/A
2023-05-08 21:26 ESTNewsAnavex Life Sciences Q2 2023 Earnings PreviewN/A
2023-05-04 09:38 ESTNewsAnavex And The Antioxidant Treatment Of Alzheimer's DiseaseN/A
2023-04-06 10:52 ESTNewsBiogen And Eisai, Cassava Sciences, And Anavex: Clinical Trial Results In Need Of RevisionsN/A
2023-03-31 01:41 ESTNewsAnavex gains on long-term data for Parkinson’s disease therapyN/A
2023-03-16 14:51 ESTNewsBuy Anavex For Its Likely Positive Alzheimer's Disease DataN/A
2023-03-08 22:50 ESTNewsAnavex: Many Questions Answered, A Few Still Left, But Things Are Progressing WellN/A
2023-02-09 22:02 ESTNewsAnavex Life Sciences: Recent Earnings Reveals Strong Cash Position To Get ANAVEX 2-73 Through FDAN/A
2023-02-07 16:44 ESTNewsAnavex Life Sciences GAAP EPS of -$0.17 beats by $0.02N/A
2023-02-07 16:44 ESTNewsAnavex Life Sciences Corp. (AVXL) Q1 2023 Earnings Call TranscriptN/A
2023-02-07 16:43 ESTNewsAnavex hits two-month high after Q1 FY23 resultsN/A
2023-02-06 15:12 ESTNewsAnavex Life Sciences Q1 2023 Earnings PreviewN/A
2023-02-02 15:43 ESTNewsAnavex gains as trial for Rett syndrome candidate exceeds enrollment targetN/A
2023-01-31 00:23 ESTNewsApproval For Anavex's Blarcamesine Looks Inevitable After Biogen's Leqembi ApprovedN/A
2023-01-17 17:52 ESTNewsAnavex: Drug Treatments For Early Alzheimer's DiseaseN/A
2023-01-12 19:56 ESTNewsAnavex: Despite Positive Spin, No Clarity On AnomaliesN/A
2023-01-06 22:58 ESTNewsLilly, Anavex, other Alzheimer's drug developers rise modestly on Biogen lecanemab approvalN/A
2022-12-21 18:35 ESTNewsHow Well Does Anavex's New Alzheimer's Drug Compare Against Biogen's New Drug?N/A
2022-12-10 07:25 ESTNewsAnavex: A Thorough Approach To The DataN/A
2022-12-08 04:30 ESTNewsAnavex Life Sciences stock slides as downgraded to neutral at Cantor FitzgeraldN/A
2022-12-06 15:57 ESTNewsAnavex Life Sciences: The Little Company That DidN/A
2022-12-04 07:23 ESTNewsAnavex's Alzheimer's Results Leave Much To Be DesiredN/A
2022-12-02 19:33 ESTNewsAnavex surges 40% as drug improves cognitive function in Alzheimer's patients, meets trial's goalsN/A
2022-12-02 19:32 ESTNewsJones sees Anavex as 'clear M&A target' after Alzheimer's drug's trial successN/A
2022-11-30 14:05 ESTNewsAnavex Life Sciences: Market Unimpressed As Major Alzheimer's Data Readout ArrivesN/A
2022-11-29 21:24 ESTNewsAnavex defended at Cantor on prospects for rare disease therapyN/A
2022-11-29 02:23 ESTNewsAnavex Life Sciences Corp. (AVXL) Q4 2022 Earnings Call TranscriptN/A
2022-11-29 02:23 ESTNewsAnavex drops 16% after fiscal 2022 updateN/A
2022-11-28 08:22 ESTNewsAnavex Life Sciences GAAP EPS of -$0.18 misses by $0.01N/A
2022-11-08 08:37 ESTNewsAnavex Life Sciences At A Pivotal MomentN/A
2022-11-07 15:31 ESTNewsAnavex therapy for Fragile X syndrome gets FDA orphan drug statusN/A
2022-09-29 23:01 ESTNewsBiogen, Eisai cool off after massive run-up following lecanemab Alzheimer's dataN/A
2022-09-21 22:13 ESTNewsAnavex wins new U.S. patent for lead candidateN/A
2022-09-19 19:30 ESTNewsAnavex Life Sciences: Upcoming Readouts In Alzheimer's And Parkinson's Disease DementiaN/A
2022-09-08 07:56 ESTNewsAnavex's Blarcamesine And Other Disease Modifying Treatments For Alzheimer's DiseaseN/A
2022-08-11 23:27 ESTNewsAnavex And The Debunking Of The Amyloid HypothesisN/A
2022-08-10 12:59 ESTNewsAnavex Life Sciences Corp. (AVXL) CEO Dr. Christopher Missling on Q3 2022 Results - Earnings Call TranscriptN/A
2022-08-09 19:18 ESTNewsAnavex Life Sciences GAAP EPS of -$0.16 beats by $0.01N/A
2022-08-08 20:39 ESTNewsAnavex Life Sciences Q3 2022 Earnings PreviewN/A
2022-08-01 22:33 ESTNewsAnavex gains on the effect of Alzheimer’s drug on genesN/A
2022-06-24 04:00 ESTNewsAnavex gains as Berenberg launches coverage with Buy ratingN/A
2022-06-02 22:17 ESTNewsAnavex's Blarcamesine: Why It May Treat Alzheimer's DiseaseN/A
2022-05-31 18:54 ESTNewsAnavex: Increasing Shareholder Value Against All OddsN/A
2022-05-11 00:41 ESTNewsAnavex Life Sciences GAAP EPS of -$0.14 beats by $0.03N/A
2022-05-11 00:40 ESTNewsAnavex Life Sciences GAAP EPS of -$0.14 beats by $0.05N/A
2022-05-11 00:40 ESTNewsAnavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q2 2022 Results - Earnings Call TranscriptN/A
2022-05-10 02:36 ESTNewsAnavex Life Sciences Q2 2022 Earnings PreviewN/A
2022-03-24 04:50 ESTNewsAnavex's Blarcamesine And Cassava Sciences' Simufilam: The Stabilization Period For Alzheimer's DiseaseN/A
2022-03-15 17:38 ESTNewsAnavex posts mid-stage biomarker data for lead candidateN/A

About Anavex Life Sciences Corp (AVXL):

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials to treat Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company is based in New York, New York.

AVXL Quotes by TradingView

See Advanced Chart

General

  • Name Anavex Life Sciences Corp
  • Symbol AVXL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 20
  • Last Split Factor1:4
  • Last Split Date2015-10-07
  • Fiscal Year EndSeptember
  • IPO Date2006-08-02
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.anavex.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 23.64
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.50
  • Next Year EPS Estimate -$0.55
  • Next Quarter EPS Estimate -$0.11
  • Return on Assets -41%
  • Return on Equity -76%
  • Earnings Per Share -$0.60
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.03 billion
  • Analyst Target Price $15.2
  • Book Value Per Share $0.69
View More

Share Statistics

  • Shares Outstanding 69.49 million
  • Shares Float 67.14 million
  • % Held by Insiders 363%
  • % Held by Institutions 19.19%
  • Shares Short 3.96 million
  • Shares Short Prior Month 4.01 million
  • Short Ratio 0.47
  • Short % of Float 6%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 0.63
  • 52 Week High $16.39
  • 52 Week Low $2.23
  • 50 Day Moving Average 12.26
  • 200 Day Moving Average 6.92
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Anavex Life Sciences Corp (AVXL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Anavex Life Sciences Corp (AVXL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-11$N/A-$0.12-$0.120%
2020-09-302020-12-28$N/A-$0.10-$0.1323.08%
2020-06-302020-08-06$N/A-$0.11-$0.1418.52%
2020-03-312020-05-07$N/A-$0.12-$0.1623.42%
2019-12-312020-02-06$N/A-$0.12-$0.120%
2019-09-302019-12-16$N/A-$0.07-$0.1552.4%
2019-06-302019-08-07$N/A-$0.14-$0.1715.71%
2019-03-312019-05-08$N/A-$0.17-$0.14-21.43%
2018-12-312019-02-07$N/A-$0.16-$0.13-23.08%
2018-09-302018-12-12$N/A-$0.13-$0.11-18.18%
2018-06-302018-08-09$N/A-$0.06-$0.1041.92%
2018-03-312018-05-10$N/A-$0.11-$0.10-10%
2017-12-312018-02-07$N/A-$0.09
2017-09-302017-12-11$N/A-$0.12-$0.10-20%
2017-06-302017-08-07$N/A-$0.09-$0.091.33%
2017-03-312017-05-10$N/A-$0.04-$0.0955.56%
2016-12-312017-02-07$N/A-$0.08-$0.1127.27%
2016-09-302016-12-12$N/A-$0.18
2016-06-302016-08-11$N/A-$0.06-$0.0924.59%
2016-03-312016-05-11$N/A-$0.06-$0.1660.81%
2015-12-312016-02-08$N/A-$0.12-$0.1414.29%
2015-09-302015-12-29$N/A-$0.21-$0.06-250%
2015-06-302015-08-17$N/A-$0.22
2015-03-312015-05-15$N/A-$0.12
2014-12-312015-02-18$N/A-$0.06
2014-09-302014-12-29$N/A-$0.20-$0.200%
2014-06-302014-08-13$N/A-$0.10
2014-03-312014-05-28$N/A-$0.11
2013-12-312014-02-26$N/A$0.03
2013-09-302013-09-30$N/A-$0.40
2013-06-302013-06-30$N/A-$0.02
2013-03-312013-03-31$N/A-$0.01
2012-12-312012-12-31$N/A-$0.06
2012-09-302012-09-30$N/A-$0.10
2012-06-302012-06-30$N/A-$0.64
2012-03-312012-03-31$N/A-$0.13
2011-12-312011-12-31$N/A-$0.33
2011-09-302011-09-30-$0.23
2011-06-302011-06-30$N/A-$0.25
2011-03-312011-03-31-$0.31
2010-12-312010-12-31-$0.31
2010-09-302010-09-30-$0.52
2010-06-302010-06-30-$0.37
2010-03-312010-03-31-$0.33
2009-12-312009-12-31-$0.09
2009-09-302009-09-30-$0.36
2009-06-302009-06-30-$0.27
2009-03-312009-03-31-$0.25
2008-12-312008-12-31-$0.19
2008-09-302008-09-30-$0.42
2008-06-302008-06-30-$0.34
2008-03-312008-03-31-$0.14
2007-12-312007-12-31-$0.19
2007-09-302007-09-30-$0.24
2007-06-302007-06-30-$0.05
2007-03-312007-03-31-$0.04
2006-12-312006-12-31$-0.00
2006-09-302006-09-30$-0.00

Anavex Life Sciences Corp (AVXL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Apr 30 2020 Mar 31 2020
Research Development N/A 6.1 million N/A N/A N/A
Income Before Tax N/A -5.96 million N/A N/A N/A
Selling General Administrative N/A 1.4 million N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A -7.51 million N/A N/A N/A
Operating Income N/A -7.51 million N/A N/A N/A
Income Tax Expense 59281 8633 4817 4817 N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A 1.54 million N/A N/A N/A
Net Income From Continuing Operations N/A -5.97 million N/A N/A N/A
Net Income Applicable to Common Shares -7.86 million -5.97 million -6.49 million -6.49 million -7.24 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Apr 30 2020 Mar 31 2020 Jan 31 2020
Investments N/A N/A N/A N/A N/A
Change to Liabilities N/A 330470 330470 N/A 522236
Total Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 7.88 million N/A 5.1 million N/A 4.37 million
Change to Operating Activities N/A 860800 860800 N/A -249184
Change in Cash 1.63 million N/A 1.06 million N/A -895352
Total Cash from Operating Activities -6.25 million -4.04 million -4.04 million N/A -5.26 million
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A -24508 -24508 N/A -24508
Change to Net Income N/A 1.25 million 1.25 million N/A 1.7 million
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Apr 30 2020 Mar 31 2020
Total Liabailities N/A 7.31 million N/A N/A N/A
Total Stockholder Equity N/A 27.24 million N/A N/A N/A
Other Current Liabilities N/A N/A N/A 24.68 million N/A
Total Assets N/A 34.54 million N/A N/A N/A
Common Stock 66964 62047 60083 N/A 58666
Other Current Assets N/A N/A N/A 60083 N/A
Retained Earnings -167.53 million -159.68 million -153.71 million -153.71 million -147.23 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets N/A N/A N/A N/A N/A
Cash N/A 29.25 million N/A 27.62 million N/A
Total Current Liabilities 8.03 million 7.31 million N/A 6.95 million N/A
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A N/A N/A N/A N/A
Total Current Assets 54.33 million 34.54 million N/A 31.63 million N/A
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 46.3 million 27.24 million 24.68 million 24.68 million 24.79 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 4.22 million 3.99 million N/A 3.98 million N/A

Anavex Life Sciences Corp (AVXL) Chart:

Anavex Life Sciences Corp (AVXL) News:

Below you will find a list of latest news for Anavex Life Sciences Corp (AVXL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Anavex Life Sciences Corp (AVXL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-04-2610CALL0 00TRUE00
2024-04-261.50CALL0 01295.17TRUE00
2024-04-2620CALL0 01030.87TRUE00
2024-04-262.50CALL0 0422.73TRUE00
2024-04-2630CALL0 0525.28TRUE00
2024-04-263.50CALL0 0350.88TRUE00
2024-04-2640.06CALL62 0126.16FALSE0.060
2024-04-264.50.05CALL0 140FALSE00
2024-04-2650.1CALL0 350FALSE00
2024-04-265.50CALL0 00FALSE00
2024-04-2660.05CALL0 30FALSE00
2024-04-266.50CALL0 00FALSE00
2024-04-2670.05CALL0 10FALSE00
2024-04-267.50CALL0 00FALSE00
2024-04-2680.05CALL0 520FALSE00
2024-04-268.50CALL0 00FALSE00
2024-04-2690.05CALL0 1320FALSE00
2024-04-26100.19CALL0 30FALSE00
2024-04-2610PUT0 00FALSE00
2024-04-261.50PUT0 00FALSE00
2024-04-2620PUT0 00FALSE00
2024-04-262.50PUT0 00FALSE00
2024-04-2630PUT0 00FALSE00
2024-04-263.50PUT0 00FALSE00
2024-04-2640.35PUT1 3397.21TRUE0.350
2024-04-264.50PUT0 0412.71TRUE00
2024-04-2650PUT0 0517.69TRUE00
2024-04-265.50PUT0 0630.04TRUE00
2024-04-2660PUT0 0691.76TRUE00
2024-04-266.50PUT0 0745.89TRUE00
2024-04-2670PUT0 0772.22TRUE00
2024-04-267.50PUT0 0859.25TRUE00
2024-04-2680PUT0 0854.55TRUE00
2024-04-268.50PUT0 0935.44TRUE00
2024-04-2690PUT0 0969.06TRUE00
2024-04-26100PUT0 01029.33TRUE00
2024-05-0310CALL0 01074.51TRUE00
2024-05-031.50CALL0 0708.5TRUE00
2024-05-0320CALL0 0544.35TRUE00
2024-05-032.50CALL0 0387.52TRUE00
2024-05-0330CALL0 0193.21TRUE00
2024-05-033.50CALL0 081.78TRUE00
2024-05-0340.15CALL2 27110.51FALSE00
2024-05-034.50.05CALL0 320FALSE00
2024-05-0350.25CALL0 190FALSE00
2024-05-035.50CALL0 00FALSE00
2024-05-0360.05CALL0 20FALSE00
2024-05-036.50CALL0 00FALSE00
2024-05-0370CALL0 00FALSE00
2024-05-037.50CALL0 00FALSE00
2024-05-0380.05CALL0 40FALSE00
2024-05-038.50CALL0 00FALSE00
2024-05-0390CALL0 00FALSE00
2024-05-03100CALL0 00FALSE00
2024-05-0310PUT0 00FALSE00
2024-05-031.50PUT0 00FALSE00
2024-05-0320PUT0 00FALSE00
2024-05-032.50PUT0 00FALSE00
2024-05-0330PUT0 00FALSE00
2024-05-033.50.35PUT0 400FALSE00
2024-05-0340.15PUT0 180.99TRUE00
2024-05-034.50PUT0 0116.07TRUE00
2024-05-0350PUT0 0296.19TRUE00
2024-05-035.50PUT0 0324.05TRUE00
2024-05-0360PUT0 0380.81TRUE00
2024-05-036.50PUT0 0593.55TRUE00
2024-05-0370PUT0 0425.34TRUE00
2024-05-037.50PUT0 0449.16TRUE00
2024-05-0380PUT0 0470.85TRUE00
2024-05-038.50PUT0 0490.75TRUE00
2024-05-0390PUT0 0509.12TRUE00
2024-05-03100PUT0 0542.11TRUE00
2024-05-1010CALL0 0765.07TRUE00
2024-05-101.50CALL0 0542.7TRUE00
2024-05-1020CALL0 0355.43TRUE00
2024-05-102.50CALL0 0259.29TRUE00
2024-05-1030CALL0 0136.14TRUE00
2024-05-103.50CALL0 0179.49TRUE00
2024-05-1040.28CALL3 0126.71FALSE0.280
2024-05-104.50CALL0 00FALSE00
2024-05-1050.13CALL0 100FALSE00
2024-05-105.50CALL0 00FALSE00
2024-05-1060CALL0 00FALSE00
2024-05-106.50CALL0 00FALSE00
2024-05-1070CALL0 00FALSE00
2024-05-107.50CALL0 00FALSE00
2024-05-1080CALL0 00FALSE00
2024-05-1090CALL0 00FALSE00
2024-05-10100CALL0 00FALSE00
2024-05-1010PUT0 00FALSE00
2024-05-101.50PUT0 00FALSE00
2024-05-1020PUT0 00FALSE00
2024-05-102.50PUT0 00FALSE00
2024-05-1030PUT0 00FALSE00
2024-05-103.50PUT0 0200.55FALSE00
2024-05-1040.47PUT0 43169.21TRUE00
2024-05-104.50PUT0 090.41TRUE00
2024-05-1051.35PUT0 179.6TRUE00
2024-05-105.50PUT0 0249.84TRUE00
2024-05-1060PUT0 0257.21TRUE00
2024-05-106.50PUT0 0325.38TRUE00
2024-05-1070PUT0 0346.07TRUE00
2024-05-107.50PUT0 0364.72TRUE00
2024-05-1080PUT0 0381.71TRUE00
2024-05-1090PUT0 0373.03TRUE00
2024-05-10100PUT0 0437.59TRUE00
2024-05-1710CALL0 0372.54TRUE00
2024-05-171.50CALL0 0456.17TRUE00
2024-05-1720CALL0 0387.55TRUE00
2024-05-172.50CALL0 0217.51TRUE00
2024-05-1730.85CALL0 4192.27TRUE00
2024-05-173.50CALL0 0178.72TRUE00
2024-05-1740.25CALL12 1398.18FALSE00
2024-05-174.50.15CALL92 0106.06FALSE0.150
2024-05-1750.1CALL88 196115.35FALSE00
2024-05-175.50CALL0 00FALSE00
2024-05-1760.05CALL0 1310FALSE00
2024-05-176.50CALL0 00FALSE00
2024-05-1770.05CALL0 4870FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-1780.05CALL0 3060FALSE00
2024-05-1790CALL0 00FALSE00
2024-05-17100CALL0 00FALSE00
2024-05-1710PUT0 00FALSE00
2024-05-171.50PUT0 00FALSE00
2024-05-1720PUT0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1730.16PUT0 1700FALSE00
2024-05-173.50PUT0 0183.35FALSE00
2024-05-1740.46PUT3 12271.27TRUE-0.09-0.16
2024-05-174.50PUT0 0162.23TRUE00
2024-05-1751.13PUT0 7220.94TRUE00
2024-05-175.50PUT0 0225.96TRUE00
2024-05-1761.79PUT0 10255.49TRUE00
2024-05-176.50PUT0 0282.45TRUE00
2024-05-1772.2PUT0 10292.66TRUE00
2024-05-177.50PUT0 0221.94TRUE00
2024-05-1780PUT0 0322.89TRUE00
2024-05-1790PUT0 0199.21TRUE00
2024-05-17100PUT0 0370.33TRUE00
2024-05-2410CALL0 0409.04TRUE00
2024-05-2420CALL0 0211.5TRUE00
2024-05-242.50CALL0 0410.96TRUE00
2024-05-2430CALL0 0115.67TRUE00
2024-05-2440CALL0 0168.13FALSE00
2024-05-2450CALL0 00FALSE00
2024-05-2460.1CALL0 160FALSE00
2024-05-2470.1CALL0 10FALSE00
2024-05-2480.05CALL1 6159.72FALSE0.050
2024-05-2490.1CALL0 550FALSE00
2024-05-2410PUT0 00FALSE00
2024-05-2420PUT0 00FALSE00
2024-05-242.50PUT0 00FALSE00
2024-05-2430PUT0 00FALSE00
2024-05-2440PUT0 0155.66TRUE00
2024-05-2450PUT0 0108.81TRUE00
2024-05-2460PUT0 0219.52TRUE00
2024-05-2470PUT0 0245.55TRUE00
2024-05-2480PUT0 0272.05TRUE00
2024-05-2490PUT0 0294.42TRUE00
2024-05-3110CALL0 0471.38TRUE00
2024-05-3120CALL0 0287.24TRUE00
2024-05-312.50CALL0 00TRUE00
2024-05-3130CALL0 0103.86TRUE00
2024-05-3140CALL0 0162.16FALSE00
2024-05-3150.21CALL0 50FALSE00
2024-05-3160.05CALL1 0102.91FALSE0.050
2024-05-3170CALL0 00FALSE00
2024-05-3180.05CALL1 0144.12FALSE0.050
2024-05-3110PUT0 00FALSE00
2024-05-3120PUT0 00FALSE00
2024-05-312.50PUT0 00FALSE00
2024-05-3130PUT0 0164FALSE00
2024-05-3140PUT0 055.47TRUE00
2024-05-3150PUT0 0241.04TRUE00
2024-05-3161.9PUT0 5313.02TRUE00
2024-05-3172.95PUT0 5210.45TRUE00
2024-05-3180PUT0 0247.03TRUE00
2024-06-2110CALL0 0165.5TRUE00
2024-06-2120CALL0 0150.76TRUE00
2024-06-2130CALL0 0120.67TRUE00
2024-06-2140CALL0 0137.95FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-2160CALL0 00FALSE00
2024-06-2170CALL0 00FALSE00
2024-06-2180CALL0 0223.76FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2120PUT0 00FALSE00
2024-06-2130PUT0 0116.45FALSE00
2024-06-2140PUT0 0118.61TRUE00
2024-06-2150PUT0 092.58TRUE00
2024-06-2160PUT0 0236.29TRUE00
2024-06-2170PUT0 0261.67TRUE00
2024-06-2180PUT0 0122.41TRUE00
2024-07-1910CALL0 0269.35TRUE00
2024-07-1920CALL0 0103.11TRUE00
2024-07-1931.5CALL0 1128.69TRUE00
2024-07-1940.5CALL14 12584.76FALSE-0.05-0.09
2024-07-1950.25CALL20 161685.53FALSE-0.03-0.11
2024-07-1960.2CALL125 1583100.8FALSE0.050.33
2024-07-1970.12CALL63 3189101.87FALSE0.071.4
2024-07-1980.1CALL122 389110.36FALSE0.10
2024-07-1990.05CALL0 4910FALSE00
2024-07-19100.15CALL0 14560FALSE00
2024-07-19110.15CALL0 2140FALSE00
2024-07-19120.15CALL0 7870FALSE00
2024-07-19130.05CALL0 2350FALSE00
2024-07-19150.05CALL0 10850FALSE00
2024-07-19200.16CALL0 1150FALSE00
2024-07-1910PUT0 00FALSE00
2024-07-1920.09PUT0 20FALSE00
2024-07-1930.27PUT0 3892.25FALSE00
2024-07-1940.8PUT0 22791.91TRUE00
2024-07-1951.05PUT0 43873.86TRUE00
2024-07-1962.55PUT12 307115.85TRUE2.550
2024-07-1973.1PUT0 2233126.56TRUE00
2024-07-1984PUT0 415151.8TRUE00
2024-07-1993.6PUT0 24183.01TRUE00
2024-07-19104.52PUT0 48177.71TRUE00
2024-07-19115.15PUT0 0222.57TRUE00
2024-07-19120PUT0 0398.66TRUE00
2024-07-19130PUT0 0216.12TRUE00
2024-07-19150PUT0 0240.62TRUE00
2024-07-19200PUT0 0296.62TRUE00
2024-10-1810CALL0 0140.32TRUE00
2024-10-1820CALL0 0128.17TRUE00
2024-10-1831.25CALL1 1290.52TRUE1.250
2024-10-1841.05CALL0 2086.97FALSE00
2024-10-1850.55CALL52 28789.15FALSE0.550
2024-10-1860.75CALL0 860FALSE00
2024-10-1870.49CALL0 1081.9FALSE00
2024-10-1880.21CALL56 14693.47FALSE0.210
2024-10-1890.5CALL0 13104.17FALSE00
2024-10-18100.2CALL0 85104.22FALSE00
2024-10-18110.2CALL0 72101.95FALSE00
2024-10-1810PUT0 00FALSE00
2024-10-1820.1PUT0 1109.64FALSE00
2024-10-1830.35PUT0 594.02FALSE00
2024-10-1840.63PUT0 5491.66TRUE00
2024-10-1851.09PUT0 4790.2TRUE00
2024-10-1862.4PUT0 796.87TRUE00
2024-10-1870PUT0 0111.97TRUE00
2024-10-1883.9PUT0 1106.34TRUE00
2024-10-1890PUT0 090.87TRUE00
2024-10-18100PUT0 0138.37TRUE00
2024-10-18116.3PUT0 2158.25TRUE00
2025-01-1710CALL0 0155.91TRUE00
2025-01-1720CALL0 0113.55TRUE00
2025-01-1731.45CALL0 11789.35TRUE00
2025-01-1741.04CALL0 10687.83FALSE00
2025-01-1750.9CALL0 150289.26FALSE00
2025-01-1760CALL0 092.44FALSE00
2025-01-1770.5CALL0 26293.61FALSE00
2025-01-1780.5CALL0 38460FALSE00
2025-01-17100.35CALL30 3474103.16FALSE00
2025-01-17120.35CALL0 131997.1FALSE00
2025-01-17150.2CALL0 278497.77FALSE00
2025-01-17170.18CALL0 859103.72FALSE00
2025-01-17200.15CALL0 1615106.62FALSE00
2025-01-17220.15CALL0 107110.84FALSE00
2025-01-17250.13CALL0 61950FALSE00
2025-01-17270.08CALL23 1399115.24FALSE-0.02-0.2
2025-01-1710PUT0 00FALSE00
2025-01-1720PUT0 0102.52FALSE00
2025-01-1730.55PUT0 34393.13FALSE00
2025-01-1741.2PUT12 086.99TRUE1.20
2025-01-1752PUT20 27294.2TRUE20
2025-01-1760PUT0 092.75TRUE00
2025-01-1773PUT0 694.97TRUE00
2025-01-1783.4PUT0 3704110.07TRUE00
2025-01-17105.9PUT0 128113.05TRUE00
2025-01-17127PUT0 2499.44TRUE00
2025-01-17159.5PUT0 67142.72TRUE00
2025-01-171710.45PUT0 26140.04TRUE00
2025-01-172015.05PUT0 0213.88TRUE00
2025-01-17220PUT0 0181.08TRUE00
2025-01-172518.8PUT0 0218.18TRUE00
2025-01-172719.2PUT0 0166.12TRUE00
2026-01-1632.68CALL0 2374.42TRUE00
2026-01-1652.4CALL0 84159.16FALSE00
2026-01-1671.45CALL0 1770FALSE00
2026-01-16101CALL2 441100.92FALSE-0.3-0.23
2026-01-16121CALL0 48198.25FALSE00
2026-01-16150.9CALL0 1246178.65FALSE00
2026-01-16200.6CALL0 307101.17FALSE00
2026-01-1631PUT0 285.63FALSE00
2026-01-1652PUT0 3290.84TRUE00
2026-01-1674.21PUT2 9101TRUE4.210
2026-01-16106.4PUT0 1881.41TRUE00
2026-01-16120PUT0 0110.75TRUE00
2026-01-16150PUT0 0161.07TRUE00
2026-01-16200PUT0 0155.84TRUE00

Latest AVXL Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST200$7.57
Jun 13, 2022 7:59 PM EST58$7.56
Jun 13, 2022 7:59 PM EST1$7.57
Jun 13, 2022 7:59 PM EST100$7.57
Jun 13, 2022 7:59 PM EST29$7.56

Anavex Life Sciences Corp (AVXL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000712/0001731122-20-000712-index.htm
2017-06-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1314052/000000000017020197/0000000000-17-020197-index.htm
2019-07-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1314052/000000000019011025/0000000000-19-011025-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1314052/000083423720008231/0000834237-20-008231-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1314052/000083423720009195/0000834237-20-009195-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1314052/000090571818000242/0000905718-18-000242-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1314052/000090571819000231/0000905718-19-000231-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1314052/000090571820000234/0000905718-20-000234-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000121390019010249/0001213900-19-010249-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000121390019010601/0001213900-19-010601-index.htm
2019-06-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1314052/000121390019010604/0001213900-19-010604-index.htm
2019-07-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1314052/000121390019012072/0001213900-19-012072-index.htm
2019-07-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1314052/000121390019012578/0001213900-19-012578-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000121390019014791/0001213900-19-014791-index.htm
2019-09-13S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1314052/000121390019018007/0001213900-19-018007-index.htm
2019-09-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1314052/000121390019018012/0001213900-19-018012-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000121390019018023/0001213900-19-018023-index.htm
2019-09-16AWAmendment Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1314052/000121390019018132/0001213900-19-018132-index.htm
2019-09-17POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1314052/000121390019018310/0001213900-19-018310-index.htm
2017-06-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1314052/000161577417003075/0001615774-17-003075-index.htm
2017-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000161577417004118/0001615774-17-004118-index.htm
2017-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004281/0001615774-17-004281-index.htm
2017-08-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004290/0001615774-17-004290-index.htm
2017-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004399/0001615774-17-004399-index.htm
2017-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004574/0001615774-17-004574-index.htm
2017-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004587/0001615774-17-004587-index.htm
2017-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004745/0001615774-17-004745-index.htm
2017-08-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004809/0001615774-17-004809-index.htm
2017-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004886/0001615774-17-004886-index.htm
2017-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004918/0001615774-17-004918-index.htm
2017-09-07424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1314052/000161577417004964/0001615774-17-004964-index.htm
2017-09-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417004994/0001615774-17-004994-index.htm
2017-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005014/0001615774-17-005014-index.htm
2017-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005088/0001615774-17-005088-index.htm
2017-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005183/0001615774-17-005183-index.htm
2017-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005226/0001615774-17-005226-index.htm
2017-09-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005351/0001615774-17-005351-index.htm
2017-09-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005440/0001615774-17-005440-index.htm
2017-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005508/0001615774-17-005508-index.htm
2017-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005604/0001615774-17-005604-index.htm
2017-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005634/0001615774-17-005634-index.htm
2017-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005731/0001615774-17-005731-index.htm
2017-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005767/0001615774-17-005767-index.htm
2017-10-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005807/0001615774-17-005807-index.htm
2017-10-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005861/0001615774-17-005861-index.htm
2017-10-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417005929/0001615774-17-005929-index.htm
2017-12-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1314052/000161577417007272/0001615774-17-007272-index.htm
2017-12-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417007355/0001615774-17-007355-index.htm
2017-12-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577417007357/0001615774-17-007357-index.htm
2018-02-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000161577418000934/0001615774-18-000934-index.htm
2018-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418001587/0001615774-18-001587-index.htm
2018-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418001629/0001615774-18-001629-index.htm
2018-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418001650/0001615774-18-001650-index.htm
2018-03-08DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418001673/0001615774-18-001673-index.htm
2018-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000161577418001701/0001615774-18-001701-index.htm
2018-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418001744/0001615774-18-001744-index.htm
2018-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000161577418002786/0001615774-18-002786-index.htm
2018-04-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418002846/0001615774-18-002846-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000161577418003574/0001615774-18-003574-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418004019/0001615774-18-004019-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418004023/0001615774-18-004023-index.htm
2018-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1314052/000161577418006278/0001615774-18-006278-index.htm
2018-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000161577418006280/0001615774-18-006280-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000161577418007805/0001615774-18-007805-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418010436/0001615774-18-010436-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418010439/0001615774-18-010439-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418010441/0001615774-18-010441-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418010443/0001615774-18-010443-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418010445/0001615774-18-010445-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418010447/0001615774-18-010447-index.htm
2018-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577418010620/0001615774-18-010620-index.htm
2018-12-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1314052/000161577418014328/0001615774-18-014328-index.htm
2019-01-2510-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1314052/000161577419001031/0001615774-19-001031-index.htm
2019-01-31PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1314052/000161577419001498/0001615774-19-001498-index.htm
2019-02-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000161577419002057/0001615774-19-002057-index.htm
2019-02-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1314052/000161577419002242/0001615774-19-002242-index.htm
2019-03-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1314052/000161577419004136/0001615774-19-004136-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000161577419004139/0001615774-19-004139-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000161577419005452/0001615774-19-005452-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000161577419007213/0001615774-19-007213-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000161577419007324/0001615774-19-007324-index.htm
2019-12-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1314052/000173112219000784/0001731122-19-000784-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000018/0001731122-20-000018-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000019/0001731122-20-000019-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000020/0001731122-20-000020-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000021/0001731122-20-000021-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000022/0001731122-20-000022-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000023/0001731122-20-000023-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000024/0001731122-20-000024-index.htm
2020-02-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000173112220000103/0001731122-20-000103-index.htm
2020-02-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000195/0001731122-20-000195-index.htm
2020-03-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000289/0001731122-20-000289-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000360/0001731122-20-000360-index.htm
2020-05-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1314052/000173112220000430/0001731122-20-000430-index.htm
2020-05-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1314052/000173112220000431/0001731122-20-000431-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000432/0001731122-20-000432-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000173112220000447/0001731122-20-000447-index.htm
2020-07-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1314052/000173112220000711/0001731122-20-000711-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000173112220000712/0001731122-20-000712-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1314052/000173112220000807/0001731122-20-000807-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000173112220001047/0001731122-20-001047-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1314052/000173112220001114/0001731122-20-001114-index.htm
2017-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1314052/999999999517001508/9999999995-17-001508-index.htm
2019-07-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1314052/999999999519001606/9999999995-19-001606-index.htm
2019-09-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1314052/999999999519002138/9999999995-19-002138-index.htm

Anavex Life Sciences Corp (AVXL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anavex Life Sciences Corp (AVXL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 363%
Institutional Ownership: 1919%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-08-11CHRISTOPHER U MISSLINGPresident and CEOBuy750.003.552,662.501,004,000.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004281/0001615774-17-004281-index.htm
2017-08-14CHRISTOPHER U MISSLINGPresident and CEOBuy375.003.701,387.501,004,375.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004399/0001615774-17-004399-index.htm
2017-08-18CHRISTOPHER U MISSLINGPresident and CEOBuy375.003.811,428.751,004,750.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004574/0001615774-17-004574-index.htm
2017-08-21CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.071,526.251,005,125.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004587/0001615774-17-004587-index.htm
2017-08-24CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.541,702.501,005,500.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004745/0001615774-17-004745-index.htm
2017-08-28CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.441,665.001,005,875.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004809/0001615774-17-004809-index.htm
2017-08-31CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.481,680.001,006,250.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004886/0001615774-17-004886-index.htm
2017-09-05CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.901,837.501,006,625.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004918/0001615774-17-004918-index.htm
2017-09-07CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.761,785.001,007,000.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417004994/0001615774-17-004994-index.htm
2017-09-11CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.811,803.751,007,375.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005014/0001615774-17-005014-index.htm
2017-09-14CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.581,717.501,007,750.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005088/0001615774-17-005088-index.htm
2017-09-18CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.401,650.001,008,125.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005183/0001615774-17-005183-index.htm
2017-09-20CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.231,586.251,008,500.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005226/0001615774-17-005226-index.htm
2017-09-26CHRISTOPHER U MISSLINGPresident and CEOBuy375.003.881,455.001,008,875.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005351/0001615774-17-005351-index.htm
2017-09-28CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.211,578.751,009,250.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005440/0001615774-17-005440-index.htm
2017-10-02CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.201,575.001,009,625.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005508/0001615774-17-005508-index.htm
2017-10-05CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.301,612.501,010,000.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005604/0001615774-17-005604-index.htm
2017-10-13CHRISTOPHER U MISSLINGPresident and CEOBuy750.004.223,165.001,010,750.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005731/0001615774-17-005731-index.htm
2017-10-17CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.271,601.251,011,125.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005767/0001615774-17-005767-index.htm
2017-10-19CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.491,683.751,011,500.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005807/0001615774-17-005807-index.htm
2017-10-24CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.921,845.001,011,875.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005861/0001615774-17-005861-index.htm
2017-10-25CHRISTOPHER U MISSLINGPresident and CEOBuy375.004.391,646.251,012,250.00https://www.sec.gov/Archives/edgar/data/1314052/000161577417005929/0001615774-17-005929-index.htm
2018-03-02CHRISTOPHER U MISSLINGDirector, President & CEOBuy1,650.002.413,976.501,013,900.00https://www.sec.gov/Archives/edgar/data/1314052/000161577418001587/0001615774-18-001587-index.htm
2018-03-05CHRISTOPHER U MISSLINGPresident and CEOBuy1,500.002.633,945.001,015,400.00https://www.sec.gov/Archives/edgar/data/1314052/000161577418001629/0001615774-18-001629-index.htm
2018-03-06CHRISTOPHER U MISSLINGPresident and CEOBuy1,450.002.733,958.501,016,850.00https://www.sec.gov/Archives/edgar/data/1314052/000161577418001650/0001615774-18-001650-index.htm
2018-03-07CHRISTOPHER U MISSLINGPresident and CEOBuy1,360.002.923,971.201,018,210.00https://www.sec.gov/Archives/edgar/data/1314052/000161577418001744/0001615774-18-001744-index.htm